Profundice en los temas de investigación de 'In adults with MI and LVEF >40% after invasive care, b-blocker therapy did not reduce a composite adverse outcome at a median 3.7 y'. En conjunto forman una huella única.
Pharmacology, Toxicology and Pharmaceutical Science